[A method of treating conjunctivitis sicca and Sjögren's disease with a secretolytic].
D000328:Adult; D000814:Aniline Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D003231:Conjunctivitis / Q000188:drug therapy*; D003514:Cyclohexylamines / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007765:Lacrimal Apparatus / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D012859:Sjogren's Syndrome / Q000188:drug therapy*; D013666:Tears / Q000378:metabolism*
D000814:Aniline Compounds; D001593:Benzyl Compounds; D003514:Cyclohexylamines; D009883:Ophthalmic Solutions
Uber eine Behandlungsmöglichkeit der Conjunctivitis sicca und des Mb. Sjógtren mit einem Sekretolytikum.